Toward the integration of personalized and systems medicine: Challenges, opportunities and approaches

Personalized Medicine

Volumn 8, Issue 1, 2011, Pages 1-4

  Yan, Qing ^a  

^a PharmTao   (United States)

Author keywords

biomarkers; genotypes; networks; pathways; personalized medicine; pharmacogenomics; phenotypes; systems biology; translational bioinformatics; wellness

Indexed keywords

BIOLOGICAL MARKER;

BIOINFORMATICS; BIOMEDICINE; GENOTYPE; HEALTH STATUS; MENTAL HEALTH; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; WELLBEING;

EID: 78650621222     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.10.77     Document Type: Review

References (23)

1. Ross CJ, Carleton B, Warn DG et al.: Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children. Ann. NY Acad. Sci. 1110, 177-192 (2007).
2. Caskey CT: The drug development crisis: effciency and safety. Annu. Rev. Med. 58, 1-16 (2007).
3. Hawks SR, Smith T, Thomas HG et al.: The forgotten dimensions in health education research. Health Educ Res. 23(2), 319-324 (2008).
4. Ray O: The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness. Ann. NY Acad. Sci. 1032, 35-51 (2004).
5. Yan Q: Pharmacogenomics of membrane transporters an overview. Methods Mol. Biol. 227, 1-20 (2003).
6. Meyer UA: Pharmacogenetics-fve decades of therapeutic lessons from genetic diversity Nat. Rev. Genet. 5, 669-676 (2004).
7. Yan Q: Pharmacogenomics in drug discovery and development. Preface. Methods Mol. Biol. 448, v-vii (2008).
8. Gréen H, Falk IJ, Lotf K et al.: Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J. (2010) (Epub ahead of print).
9. Vodovotz Y, An G: Systems biology and infammation. Methods Mol. Biol. 662, 181-201 (2010).
10. Martin H: Role of PPAR-γ in infammation. Prospects for therapeutic intervention by food components. Mutat. Res. 690(1-2), 57-63 (2010).
11. Bassaganya-Riera J, Song R, Roberts PC et al.: PPAR-γ activation as an anti-infammatory therapy for respiratory virus infections. Viral Immunol. 23(4), 343-352 (2010).
12. Yan Q: Translational bioinformatics and systems biology approaches for personalized medicine. Methods Mol. Biol. 662, 167-178 (2010).
13. Yan Q: The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery Methods Mol. Biol. 448, 1-19 (2008).
14. Yan Q: Immunoinformatics and systems biology methods for personalized medicine. Methods Mol. Biol. 662, 203-220 (2010).
15. Godbout JP, Glaser R: Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J. Neuroimmune Pharmacol. 1(4), 421-427 (2006).
16. Marques-Deak A, Sternberg E: Psychoneuroimmunology-the relation between the central nervous system and the immune system. Rev. Bras. Psiquiatr. 26(3), 143-144 (2004).
17. Goncharova LB, Tarakanov AO: Molecular networks of brain and immunity. Brain Res. Rev. 55(1), 155-166 (2007).
18. Skurlova M, Stofkova A, Jurcovicova J: Anxiety-like behavior in the elevated-plus maze tests and enhanced IL-1ß, IL-6, NADPH oxidase-1, and iNOS mRNAs in the hippocampus during early stage of adjuvant arthritis in rats. Neurosci. Lett. (2010) (Epub ahead of print).
19. Harden LM, du Plessis I, Roth J et al.: Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1ß and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology (2010) (Epub ahead of print).
20. Wulfkuhle JD, Edmiston KH, Liotta LA et al.: Technology insight: pharmacoproteomics for cancer-promises of patient-tailored medicine using protein microarrays. Nat. Clin. Pract. Oncol. 3(5), 256-268 (2006).
21. Chung CC, Magalhaes WC, Gonzalez-Bosquet J et al.: Genome-wide association studies in cancer-current and future directions. Carcinogenesis 31(1), 111-120 (2010).
22. Camp RL, Dolled-Filhart M et al.: X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cutpoint optimization. Clin. Cancer Res. 10, 7252-7259 (2004).
23. Daemen A, Gevaert O, Ojeda F et al.: A kernel-based integration of genome-wide data for clinical decision support. Genome Med. 1, 39 (2009).